COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Debt / NOTE 2.625% 2/1
Unit price / market price
$1.01
Total 13F principal
$26,039,566
Principal change
+$1,020,000
Total reported value
$26,440,939
Number of holders
7
Value change
+$1,014,900
Number of buys
1

Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 as of Q2 2023

As of 30 Jun 2023 COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 had 7 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of $26,039,566 principal (par value or face value) of the bond of the company.
Largest 7 bondholders included Polar Asset Management Partners Inc., CSS LLC/IL, MORGAN STANLEY, DeepCurrents Investment Group LLC, Raab & Moskowitz Asset Management LLC, GREAT VALLEY ADVISOR GROUP, INC., and Verition Fund Management LLC.
This table shows 7 bond principal holders of the security as of 30 Jun 2023.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.